Nephros CEO’s 120,000‑Share Buy Signals Strong Growth in Hemodiafiltration Market
Nephros Inc’s CEO buys 120,000 shares, selling options—signals strong insider confidence in its hemodiafiltration growth, while consumer tech‑savvy trends boost demand for advanced dialysis solutions.
5 minutes to read

